Related Experiment Video
Updated: Jul 30, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program
1Department of Pharmacy Practice, Campbell University School of Pharmacy, Buies Creek, North Carolina, USA.
Abstract:
Low-molecular-weight heparins are safe and effective for outpatient treatment of deep vein thrombosis (DVT). An outpatient DVT treatment program was established in a 532-bed nonprofit teaching hospital. With the cooperation and skills of a multidisciplinary team, 125 patients were treated for acute DVT primarily at home over 26 months. Preliminary results demonstrated a drop in average length of hospitalization from 5.4 days before the program to 0.97 days. All patients successfully completed a course of enoxaparin, averaging 5.23 days, with 4.26 days of treatment as outpatients. One hundred twenty-two patients (97.6%) required no rehospitalization for any reason, including recurrence of DVT and bleeding complications, throughout the 90-day anticoagulation treatment course. The hospital achieved a cost avoidance of $2470.68/patient. For all 125 patients, total cost avoidance was $308,835.17.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management

